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Biochemical Characterization and Gene Mapping the Channel
Catfish Herpesvirus (CCV)-Encoded Thymidine Kinase,
a Selectable Site for Homologous Recombination

Abstract
The channel catfish herpesvirus (CCV) encodes a thymidine
kinase (Tk) which is biochemically distinguishable from it's
host, the channel catfish ovary (CCO), and other herpesvirus
Tk's.

Tk

deficient

propagating

CCO

cells

(CCOBr)

were

developed

by

CCO cells in increasing concentrations of 5-

bromo-2'-deoxyuridine (BUdR). CCV infection produced high Tk
activity

in these Tk deficient cells.

This activity was

compared to CCO-Tk in ATP and CTP phosphate donor assays,
nucleoside substrate-competition and dTTP feedback inhibition
assays.

The viral Tk was more competitively inhibited by

deoxypurines than cellular Tk and showed less dTTP mediated
feedback inhibition.

CCO-Tk utilized lower concentrations of

ATP more effectively than CCV-Tk.
utilized CTP as a phosphate donor.
other

herpesvirus

Tk's

mammalian herpesviruses.
CCV genome,

and

Neither CCV-Tk nor CCO-Tk
This is in contrast to

indicates

a

divergence

from

To map the CCV-Tk gene within the

a Tk-negative mutant

of CCV was

isolated

by

passing the virus in the presence of BUdR and then selecting
an

isolate

(CCVAr)

that

was

resistant

to

1

mM

1-B-D-

arabinofuranosylthymine

(Ara-T).

A CCV incomplete genomic

library was constructed by cloning restriction endonuclease
EcoRI digested viral DNA into plasmid pUC-19.
library

was

constructed

into

cosmid

partial EcoRI digest of viral DNA.

pHC-79

A complete
by

cloning

a

Four cosmid clones were

isolated that collectively encompassed 98% of the genome.

The

cosmid CCV-DNA clones and the pUC-19 subfragments were used
in

cationic-liposome

mediated

co-transfections

CCVAr-DNA in marker-rescue assays.

with

whole

CCVAr rescue, scored by

14CdT mediated plaque autoradiography on CCOBr cells, mapped
the mutation within the direct repeat ends of the genome.

x

Introduction

Immunization has long been used as a disease control in
human and veterinary medicine, but only recently has work been
started on vaccines for aquatic animals.

Presently the only

vaccines registered for aquatic animals are for cold-water
fish.

This

is

because

most

cold

water

operations

intensive systems with readily accessible stocks.

are

Work on the

immunization of warm-water fish and other aquatic animals is
needed to give aquaculturists another tool to combat disease
problems and increase production.
Most warmwater aquaculture operations are extensive
operations containing vast numbers of fish.

Individual fish

have a relatively low value and there is very little direct
handling of the stocks.
vaccination

program

Therefore, any successful warm water

must

use

extensive

vaccine

techniques such as immersion or oral application.

delivery

Using these

methods with killed antigen preparations can induce protective
immune responses in fish, but require large volumes of antigen
that are taken up in relatively low doses and persist in the
target animal for a short period. The result is a relatively
1

weak

and

vaccines

short
are

lasting

effective

immune

response.

immunogens

Live

attenuated

the

attenuated

because

pathogen enters the target animal via it's natural invasion
mode, resulting in efficient uptake. Subsequent replication
of the agent results in antigen amplification and persistence,
which induces a stronger, longer lasting response.
Live

attenuated

vaccines

have

not

been

used

in

aquaculture due to the potential of the agent to revert to a
virulent form.

Reversion occurs when the attenuating mutation

is masked by a second mutation that makes the agent more like
the

wild

type

pathogen

(Almond

and

Cann,

1984) .

Traditionally, attenuated viral vaccines have been developed
by culturing the virus in cells from non-host species or under
unnatural

environmental

conditions.

This

mutations that make the pathogen less virulent.

selects

for

Most of these

mutations are simple base changes which can revert.

However,

recent advances in genetic recombinant technology enable live
vaccine

agents

Pathogens

can

to

be

constructed

be

permanently

which

attenuated

can
by

not

revert.

deletion

or

insertion mutations in genes coding for virulence factors.
These mutations cannot revert by simple base changes.

In

addition, the insertion and expression of foreign genes in
these agents have led to a rapid expansion of live vaccine
research.
recombinant,

The techniques
attenuated

that were developed

poxvirus

and

to produce

herpesvirus

vaccine

vectors for mammalian hosts, can be used to develop a safe

attenuated channel catfish virus vaccine.

Furthermore, this

engineered virus can be used as a vector to express other
protective immunogens, providing a broad spectrum vaccine for
the catfish industry.
Effective recombinant viral vaccine vectors require both
a large genome which can accommodate foreign genes,

and a

selectable genetic site for the insertion of foreign genes.
The viral thymidine kinase

(Tk) gene has been effectively

exploited as a selectable site of insertion for poxvirus and
herpesvirus vectors (Shih et al, 1984, Mackett et al., 1984).
Insertions or deletions of genetic material at the Tk gene
locus inactivates the Tk gene and results in attenuation (Kit
et al, 1985a, Kit et al, 1985b, Buller et al, 1985, Roizman
et al, 1984) .
Channel Catfish Virus (CCV) is a herpesvirus that causes
disease (CCVD) in young channel catfish fingerlings.

CCV can

cause high mortality, decreased growth, and a predisposition
of

the

catfish

to

fingerling ponds.

bacterial

diseases

in

heavily

stocked

Although large juvenile and adult fish are

susceptible to CCV

(Bowser et al.,

1985;

Hedrick et al.,

1987), CCVD outbreaks are rare in these populations (Plumb,
1978; McGlamery and Gratzek, 1974).
(130,000

base

pairs),

foreign gene insertion.
first

step

in

suggesting

The CCV genome is large
that

it

can

accomodate

Isolating the CCV Tk gene is the

constructing

a

permanently

negative CCV for initial use as a vaccine.

attenuated,

Tk

Once developed,

the

attenuated

CCV

could

be

used

as

a

vector

for

the

engineering of polyvalent live vaccines against other catfish
diseases.

Accordingly, the purpose of this project was to

determine if CCV induces Tk activity in the infected cell, to
distinguish the viral Tk from the cellular Tk, and to locate
the Tk gene on the genome.

In the process,

methods

for

producing recombinant CCV was established which will allow the
production
research.

of

Tk

negative

recombinant

CCV

for

vaccine

5
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Chapter One
Literature Review

The channel catfish virus
The channel catfish virus (ictalurid herpesvirus l) is
an a herpesvirus that can cause significant disease (CCVD) in
channel

catfish

fingerlings
Darlington,

(Ictalurus

(Fijan,
1971).

1968;

punctatus)

Fijan

et

fry

al.,

and

1970;

young

Wolf

and

The acute form of CCVD can decimate a

heavily stocked pond of small fingerlings or fry (up to 10cm)
in 7 days.

However, the host range of CCV is very limited.

The channel catfish is the only known natural host of CCV.
Fingerling blue catfish

(I^_ furcatus^

catfish

be

hybrids

intraperitoneal

can

injection

and channel

experimentally

but

are

resistant

x blue

infected
to

oral

immersion exposures of CCV (Plumb and Chappell, 1978).

by
and

Brown

bullheads (1^. nebulosis) , yellow bullheads (I_-_ natalis) , white
catfish

(I_s_ catus)

(Silurus glanis)

(Plumb,

1978) , and

European

sheatfish

(Plumb et al., 1985) are resistant to oral

and immersion exposures and intraperitoneal injections of CCV.
Disease

is characterized by

a viremia,

with

highest

replication occurring in the head and trunk kidneys and liver.
Late in the infection titers increase in the intestine and
brain

(Plumb,

ascites

and

swimming.

1971).

Clinical

neurological

signs include exopthalmia,

disorders

that

induce

corkscrew

Survivors are considered to be carriers for life

as indicated by DNA-DNA hybridization studies (Wise and Boyle,
1985),

and

reactivation

of

virus

from

leukocytes

immunosuppressed adult fish (Bowser et al., 1985).

of

Evidence

strongly suggests vertical transmission of the disease from
the carriers.

Serum neutralization titers from stocks of

adult channel catfish that produced CCV diseased offspring for
two consecutive years were 10 to 105 fold higher than control
fish

(Plumb,

1973b).

Also,

immunoflourescence analysis of

primary cultures from spent ovarian tissue of suspected CCV
carriers showed the expression of CCV antigens (Plumb et al.,
1981),

suggesting possible transmission of CCV in ovarian

tissue.

Experimental evidence indicates CCVD survivors have

reduced

growth

rates.

intraperitoneally

Fingerlings

challenged

with

CCV

2

g
and

reduced growth rates (McGlamery and Gratzek,

in

size

were

survivors
1974).

had

Larger

unexposed juveniles and adults are susceptible to experimental
infections

and can develop an acute form of disease (Bowser

et al., 1985; Hedrick et al., 1987) but natural epizootics in
large

fish are

rare

(McGlamery and Gratzek,

1974;

Plumb,

1978;).

Recent evidence suggests that CCV may infect many

fish populations without any overt signs of disease (Wise et
al., 1985).

DNA-DNA hybridization data indicate many catfish

populations carry the virus even though they have no history
of CCVD.
high

The expression of overt disease may be dependent on

stocking

(McConnell

density,

and

susceptibility.

predisposing

Austen,

1978;

Plumb

et

environmental

Plumb,

al.

(1975)

1978)

stress

and

showed

strain

that

CCVD

mortality in different strains of channel catfish after oral
CCV exposure ranged from 10 to 71% with hybrid strains showing
the lowest mortality.

Another factor that may affect disease

expression is the environmental temperature at the time of
exposure.

Plumb (1973a) showed that at 19 C, CCV produced

much lower mortalities in fingerlings than at 28 C.
Catfish develop a strong immune response to CCV when
exposed to live virus.
of

CCV

(Noga

A patented, live, attenuated strain

and Hartman,

1981)

was produced

by

passage

through walking catfish (Clarius batrachus) cells, Walczache
et al.

(1981)

showed significant protection in fry.

Awad

(1988) found that eggs and 1 week old fry were immunized for
CCVD after exposure to a soluble envelope preparation from
CCV.

However, the characteristics of the protective immunity

have not been studied.

Much research has been focused on

neutralizing antibody activity
variable results.
of

CCV

may

or

in survivors of CCVD,

with

Fingerlings that have survived outbreaks
may

not

produce

detectable

neutralizing

antibodies (Amend and McDowell, 1983).

Some adult survivors

retain detectable neutralizing antibodies years
productive infection (Plumb, 1973) .

after the

Some of the variability

in production of neutralizing antibodies can be caused by
differences
fish's

in the

ambient

immune response

temperature,

which

(Hedrick et al.,

affect

1987).

the

Although

neutralizing antibodies are probably a minor portion of the
fish's protective immune response to CCV, high titers are an
indicator of antigen expression from latent infections.

Other

important portions of the antiviral immune response that have
not been addressed are cytotoxic T lymphocyte responses and
non-neutralizing

antibodies

that play

a role

in

antibody

dependent cell cytotoxicity and complement mediated lysis.
The host specificity of CCV is maintained in cultured
cells.

CCV

only

replicates

in

cell

lines

derived

from

catfish, with the highest titers produced in two Ictalurid
cell lines.

Brown bullhead cells

(BB) produce up to 107'5

PFU/ml (Wolf and Darlington, 1971) and channel catfish ovary
cells

(CCO)

produce up to 108 PFU/ml

(Bowser and Plumb,

1980), while walking catfish (Clarius batrachus) cells (K1K)
produce up to 105,5 PFU/ml (Walczak et al., 1981).

The virus

replicates at temperatures ranging from 10 to 33 C in cell
culture, with highest titers at 30 C in CCO cells (Bowser and
Plumb,

1981).

characterized

CCV
by

radiating spindles.

induces

syncytia

that

cytopathic
contract

effect
to

clumps

(CPE)
with

The replication cycle from adsorption to first infectious
progeny

takes

4

hours

at

30

C

and

as

typical

of

a

herpesviruses, temporal regulation of protein synthesis and
a shutdown of host macromolecule synthesis occurs (Dixon and
Farber, 1980) . Denaturing polyacrylamide gel electrophoresis
of infected cell extracts has been used to identify at least
32

unique

expressed

viral
in

induced

three

proteins.

temporal

These

groups

and

proteins

kinetic

were

analyses

indicate that their synthesis is coordinately regulated (Dixon
and

Farber,

1980).

polypeptides.

The

virion

Non-denaturing

contains

18

electrophoretic

of

these

analysis

of

infected cell lysates (Huston, 1979), and susceptability to
viral thymidine kinase activated antiherpetic agents (Buck and
Loh,

1985)

indicate this herpesvirus codes for a thymidine

kinase like other a herpesviruses.
The physical characteristics of the CCV genomic DNA have
been well characterized.

Buoyant density analyses indicate

the overall base composition is 56% G+C (Goodheart and Pummer,
1975).

Chousterman et al.

(1979)

used restriction enzyme

mapping to show the genome is 86 x 106 daltons composed of a
62 x 106 dalton unique sequence flanked by 12 x 106 dalton
direct repeats.

These results were supported by Dixon and

Farber (1980) who analyzed the genome by electron microscopy,
sucrose gradient centrifugation and reassociation kinetics.
They also found the virus genome contained alkaline labile
sites

similar

to

other

herpesviruses.

A

comparison

of

intracellular and extracellular viral DNA restriction-enzyraefragment

electrophoretic

patterns

indicates

that

the

intracellular replicative DNA does not contain the terminal
restriction fragments.

Instead, it contains a new fragment

the size of a product produced if the ends of the virion DNA
molecules were fused (Cebrian et al., 1983).
new

fragment

requires

repeated sequences.

the

loss

of

one

The size of the

of the

terminally

This "endless" form of replicative DNA

is a typical form of herpes viral DNA and could be caused by
a circularization of the viral

DNA followed by a rolling

circle mechanism of replication that produces concatamers that
are cleaved and packaged into virions.

Sequence analysis of

portions of the 18 kb direct repeats show the following:

The

right end of the genome has a 3' single base overhang and the
left end is blunt.

There are sequences with homology to

putative herpesviruses packaging sequences within 50 bp of
each end.

The repeat region contains an open reading frame

for a 230 amino acid polypeptide with sequence conservation
to herpesvirus protein kinases (Lacosa et al., 1989).

Viral Vectors
Much

of

the

early

work

in

molecular

virology

was

performed on small DNA viruses, especially the Polyoma SV-40
group (Sambrook et al.,

1973, Sebrung et al., 1971).

This

basic research focused on genome structure, gene regulation

and the function of gene products in infected cells, as well
as the structure of the genome.

Early viral vector research

concentrated on the small DNA viruses (SV-40 and polyoma) and
retroviruses (reviewed by Rigby, 1982).
used

as

eukaryotic

expression

These viruses were

vectors

plasmids occur in higher eukaryotes.

since

no

natural

This research has been

important in identifying useful promoter, enhancer and origin
of replication sequences which led to the development of very
efficient shuttle vectors.
sequences

that enable

eukaryotic cells.
amplified

in

a

The shuttle vector carries DNA

it to replicate

Thus,

in prokaryotic

it can be manipulated

prokaryotic

host,

then

and

in vitro,

transferred

to

a

eukaryotic host for expression of cloned eukaryotic genes.
The vector can then be transferred back to a prokaryotic host
for further manipulations.

The basic components of shuttle

vectors consist of a prokaryotic origin of replication and a
selection system (generally derived from bacterial plasmids
or bacteriophage), gene regulatory elements and an origin of
replication

(generally

derived

from viruses

which

infect

eukaryotic cells). By taking advantage of the characteristics
of each viral

system,

highly specialized plasmid or viral

shuttle vectors have been established for transient high level
expression, stable constitutive expression or stable inducible
expression

in

a variety

of

cell

types.

Retroviral

and

adeno-associated viral shuttle vectors have been especially
useful for inserting small sequences of cloned DNA into cell

13

genomes.
The current system of choice for producing large amounts
of eukaryotic proteins is the insect baculovirus system (Emery
and Bishop, 1987; Luckow and Summers, 1988).
are

large

DNA

proteinaceous

viruses

that

occlusion bodies

produce

Baculoviruses

large

intranuclear

for protecting the progeny

virions from adverse environmental conditions.

The occlusion

body protein constitutes 1 mg/ml per 106 cells
cell

cultures

occlusion body

and

is

non-essential.

(polyhedrin)

By

of infected

replacing

the

gene of Autoaraoha californica

nuclear polyhedrosis virus (AcMNPV) with the desired foreign
gene,

the

Research

foreign
from

gene

is

mosquito

expressed

cell

lines

in

copious

indicate

amounts.
that

the

post-translational glycosylation in insect cells includes only
the simple manose rich "backbone" of the complex glycosylation
found in vertebrates (Buttrose and Hughes, 1981).
recombinant

mammalian

cell

products

Yet, the

expressed

from

baculovirus systems are functionally active.

Vaccine Vectors
In

the

early

1980's,

researchers

began

to

use

recombinant techniques on large DNA viruses to study gene and
protein functions (Knipe et al., 1978; Moss et al., 1981; Weir
et al., 1982; Nakano et al., 1982;
It

became

apparent

that

members

Sam and Dumbell, 1981).
of

the

poxvirus

and

herpesvirus families were uniquely suited to express large

amounts of genetic information.
useful

This property is extremely

for live virus vaccine vectors,

because

the genes

encoding protective antigens from several pathogens could be
expressed in one vector inducing protective immunity to each
pathogen.
of

Initial research was focused on the vaccinia virus

the poxviridae

herpesviridae.

and herpes

of

the

families allowing for rapid progress and

refinement of techniques.
these

(HSV)

These viruses were the most characterized of

their respective

of

simplex virus

viruses

Manipulation of genetic sequences

requires

the

in-vitro

manipulation

and

cloning of a viral genomic fragment into E^_ coli vectors using
molecular cloning techniques, followed by the transfection of
this fragment into a live cell containing the replicating
viral

DNA.

During

recombination

may

the

occur

unaltered viral sequences
cloned fragment,

replication
between

process,

the

viral

marker

so

DNA

and

the

flanking the altered DNA in the

allowing the insertion of the manipulated

sequence into a complete viral genome.
recombination

homologous

systems

involve

recombinants

can

insertion
be

The most efficient
into a selectable

quickly

identified

and

characterized.
The earliest and most commonly used selectable marker
for

insertion

is

the

viral

thymidine

(Mocarski et al., 1980; Post et al.,

kinase

(Tk)

gene

1982; Mackett et al.,

1982; Smith et al., 1983). In this system the foreign gene is
inserted into the Tk gene giving the recombinant virus a Tk

negative phenotype.

The Tk negative recombinants can then be

selected based on their resistance to Tk-activated, toxic
thymidine

analogs

such

as

5-bromo-2'-deoxyuridine

(BUdR).

Other recombination systems use non-essential glycoprotein
genes in conjunction with black plaque selection (Saur et al.,
1987) or inserted reporter genes, such as E^. coli lac Z gene
with

5-bromo-4-chloro-3-indolyl-D-galactopyranoside

(X-gal)

staining (Spaete and Mocarski, 1987; Panicali et al., 1986)
as selectable sites of insertion.

These systems use visual

selection to

identify the glycoprotein or lac

Z negative

recombinants.

An alternative method for selecting recombinant

viruses is to include a dominant selectable gene as part of
the insertion sequence, such as host range genes into a host
range mutant virus (Perkus et al., 1989), neomycin resistance
gene (Franke et al., 1985) in conjunction with Genticin 148
selection and E_s_ coli lac Z gene with

X-gal color selection

(Chakrabarti et al., 1985).
Vaccinia

virus

has

been

the

vector

of

choice

for

recombinant live virus vaccine research for several reasons:
1. it has been well established as an effective agent in the
eradication of smallpox (WHO, 1980)
only

a

localized

epidermal

2.

infection

it generally causes
3.

the virus

is

resistant to desiccation making it a good vaccine agent for
third world countries where storage problems are common

4.

it

is

does

not

non-oncogenic

establish
6.

a

latent

infection

5.

it

it has a large stable genome that can
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accommodate as much as
(Smith and Moss, 1983)

25,000 bases
7.

of

foreign sequences

it has a broad host range, making

it a candidate for human and veterinary vaccines as well as
providing non-primate animal models for vaccine research.
The ability of poxviruses to retain their infectivity in
the environment for prolonged periods and the broad host range
of vaccinia have hampered field use of recombinant agents due
to safety concerns.
threat

toman

and

The broad host range also increases the
thus

veterinary vaccines.
serious

limits

the

use

of

vaccinia

based

In rare instances vaccinia can cause

complications

especially

in

very

young

and

immunocompromised individuals (Redfield et al., 1987; Lane et
al.,

1969).

developing

Researchers have addressed these problems by
vaccine

vectors

for

veterinary

use

from

more

species specific poxviruses (Esposito et al., 1988; Boyle and
Coupar,

1986)

and

by

developing

less

virulent

forms

of

vaccinia (Buller et al., 1985; Flexmer et al., 1987; Ramshaw
et al., 1987).
Research into increasing the efficiency of vaccinia virus
as a vaccine vector includes increasing the levels of foreign
gene

expression

products.
gene

and

increasing

Fuerst et al.

the

immunogenicity

of

the

(1987) obtained high level foreign

expression using a bacteriophage T7-vaccinia hybrid.

This virus codes for a T7 RNA polymerase and contains the
foreign gene just below a T7 promoter.
extremely high

level

of

The result is an

foreign gene mRNA production

and
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concurrent high level protein expression.
(1986)

and

Vijaya

immunogenicity

of

et

al.

(1988)

secreted

Langford et al.

have

proteins

increased

by

attaching

the
a

transmembrane anchor sequence to the gene.
Because

of

human

risk

and

the

ability

to

establish

latency, HSV vaccine vectors have met with more skepticism
than vaccinia vectors.

The focus on HSV based vaccine vectors

has been to establish a safe live vaccine to HSV-1 and HSV-2
infections as well as immunize humans against other important
pathogens.

Much of this research has been concerned with

making HSV vectors safe for humans
Meigner et al., 1988).

(Roizman et al.,

1984;

By inactivating non-essential viral

genes and subsequently assessing the effects on virulence in
rodents and lower primates, novel, less virulent vectors which
have

been

created

(Longnecker

et

al.,

1988).

The

recombination techniques developed by Knipe et al.,

(1978)

allowed the pioneering of Tk based deletion and insertion
systems (Mocarski
al., 1982).

et al., 1980; Post et al., 1981; Post et

Early investigations showed that spliced as well

as unspliced eukaryotic genes could be efficiently expressed
from HSV vectors
production

of

(Post et al.,

recombinant

1982).

vectors

This

expressing

lead to the
protective

antigens from other pathogens for vaccine purposes (Shih et
al., 1984).
The knowledge gained from initial recombinant research
has been used in the development of HSV based episomal genetic

elements for gene therapy (Palella et al., 1989; Geller and
Breakefield,

1988).

HSV based gene therapy is especially

attractive for treatments of genetic nervous disorders such
as Lesch-Nyhan syndrome which is caused by a rare mutation in
which the neurons lack dehydrofolate reductase expression.
The HSV vectors are large enough to accept eukaryotic genes
containing all of the control elements and splice sequences.
Also, HSV readily infects and establishes latency in neurons.
Therefore,

the

overall

goal

is

to

construct

replication

deficient HSV vectors that can infect and establish latency
as a stable episomal element expressing foreign genes in a
cell-controlled, regulated fashion.
The techniques developed for HSV research have also been
applied to other herpesviruses, leading to the development of
several unique vector systems.

The Epstein-Barr virus (EBV)

has been genetically dissected and important control elements
have been used to create efficient eukaryotic plasmids with
wide host ranges (Yates et al., 1985; Jalanko et al., 1988;
Young et al., 1988;Hammerschmidt and Sugden, 1988).

Because

the EBV derived plasmids are stable in cell culture and can
express

inserted

shuttle

vectors

cDNA,
for

they have

screening

(Margolskee et al., 1988).

been

used

eukaryotic

as

efficient

cDNA

libraries

In this system, positive cells are

selected by fluorescent activated cell sorting and cultured
to increase the number of positive cells.

The plasmids are

then extracted from the cells and transferred into E. coli
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where they are amplified for further analyses.
Recent cytomegalovirus (CMV) research indicates that this
virus has great potential as an expression vector.

As much

as 1% of the total cellular protein has been expressed from
foreign genes under the control of 6 2.7 promoter in the CMV
genome (Spaete and Mocarski, 1987).

Because the CMV does not

contain a Tk gene, an inserted Ej_ coli lac Z gene was used as
a selectable marker.

The CMV used in this research was the

Towne strain which is attenuated and appears to be incapable
of establishing latency in human trials.

Therefore, the CMV

recombinants are candidates for human vaccine vectors.
Another non-pathogenic human strain of herpesvirus with
potential

as

a vaccine

vector

is

the

Oka

strain

of

the

varicella-zoster virus (VZV). This live virus vaccine strain
has been shown to be safe even in immunocompromised patients.
Therefore,

Lowe

et

al.

(1987)

developed

a

Tk

based

recombination system for this virus with an initial goal of
establishing a combination VZV-EBV vaccine.
A non-oncogenic deletion construct
1985a)

of the

T

lymphotrophic

7

(Desrosier et al.,

herpesvirus,

herpesvirus

saimiri, has been used to express foreign genes in primates
(Desrosiers et al., 1985b).

Because this construct is non-

pathogenic and readily establishes latency in T lymphocytes,
researchers are using this vector system for gene therapy and
immunological studies (Clark, 1987).
The pseudorabies virus (PRV) has been the most studied

herpesvirus candidate for a veterinary vaccine vector.
selectable

sites

for

homologous

recombination

have

Two
been

identified in PRV: the Tic locus and the glycoprotein X(gX)
locus.

Thymidine

kinase

negative,

bioengineered

PRV are

highly attenuated and effective vaccines for pigs (Kit et al.,
1985a) .

The use of the gX insertion in addition to the Tk

gene site allows the production of a polyvalent vector and
because the vaccine strain would be gX negative, rapid humoral
screening could be used to determine if stocks of pigs have
been exposed to the wild type virus (Thomsen et al., 1987a;
Marchioli et al. 1987; Thomsen et al., 1987b).

Furthermore,

rearranging the location of an essential gene into the Tk
locus should prevent any genomic recombination with a wild
type virus that could make the vector Tk positive (Post and
Thomsen, 1988).
(1987)

One unique tool developed by Sauer et al.,

is a bacteriophage P-l Cre-lox mediated, site specific

insertion

system

for

accurately

sequences into viral DNA in vitro.

inserting

foreign

DNA

Another alternative to in

vivo insertion of foreign DNA is the manipulation of cloned
fragments

in vitro,

then the production of live virus by

transfecting overlapping cosmid cloned genomic fragments (van
Zijl et al., 1988).
Other

herpesvirus

vaccine

vector

candidates

being

developed for veterinary use are bovine herpesvirus type 1
(BHV-1)
2)

(Kit and Kit, 1986), bovine herpesvirus type-2 (BHV-

(Sheppard and May,

1989),

and feline herpesvirus

(FHV)
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(Nunberg et al., 1989) . All of these vector systems are based
on using the Tk gene as a selectable site of recombination and
as a deletion site for attenuation.

Thymidine Kinase
By coding for a large portion of the metabolic enzymes
needed for replication, herpesviruses are less dependent on
host

cell

functions

and

can

productively

infect

replicating, differentiated cells such as neurons.

non

Many of

the non-structural genes that herpesviruses encode are enzymes
that

are

important

replication.
polymerase

nucleotide

metabolism

and

DNA

Herpesviruses have been found to encode a DNA
(Weissbach et al., 1973;

exonuclease

(Preston

glycosylase
triphosphatase
reductase

in

and

(Carradonna
(Preston

Cordingly,
et

and

(Trimble et al.,

al.,
Fisher,

1988),

Boezi

et al.,

1982),
1987),

1974),

uracil

DNA

deoxyuridine

1984) , dihydrofolate

ribonucleotide reductase

(Ponce de Leon, 1977; Dutia, 1983), thymidine kinase (Dubbs
and Kitt, 1964) and thymidylate synthase (Honess et al, 1986;
Bodemer et al., 1986).

Thymidine kinase is the most studied

of these enzymes because herpesvirus Tk plays a central role
in activating several herpesvirus specific antiviral agents
such as 9-(2-hydroxyethoxymethy1)-guanine, (acyclovir) (Elion
et al., 1977), 1-B-D arabinofuranosylthymine,

(Ara-T)(Aswell

et al., 1977) and 5-bromodeoxycytosine (Doberson and Greer,
1978) .

Tk is a pivotal enzyme in the salvage pathway for the
synthesis of deoxythmidine triphosphate (dTTP), a necessary
precursor for DNA synthesis.

Tk phosphorylates deoxythymidine

(dT) to deoxythymidine monophosphate (dTMP) which is further
phosphorylated to dTTP by thymidylate kinase.

Eukaryotic

cells

Tk

contain

two

mitochondrial Tk

Tk

isozymes,

(Kit et al.,

a

cytoplasmic

and

1973; Lee and Cheng,

a

1976).

Cells contain a thymidine transport mechanism on the cell
membrane (Plageman et al., 1988) to transport the hydrophilic
thymidine molecule into the cell.
have

enhanced

uptake

of

Herpesvirus infected cells

nucleosides

via

viral

induced

diffusion mechanism, possibly due to increased "leakiness" of
the cell membrane (Palu et al., 1990).
Of

seventeen

herpesviruses

analyzed,

all

but

cytomegalovirus and herpesvirus aotus code encode a Tk (Table
1) . Generally, herpesvirus encoded thymidine kinases are less
substrate

specific

counterparts

and

less

(Table 1) .

regulated

than

the

cellular

The cytoplasmic Tk of eukaryotic

cells are strongly inhibited by dTTP, do not phosphorylate dC
or Ara-T and cannot use CTP as a phosphate donor.

Herpesvirus

Tk's are not strongly inhibited by dTTP, they phosphorylate
Ara-T and can use CTP as a phosphate donor.

Some herpesvirus

Tk's can phosphorylate dC, others cannot.

The mitochondrial

Tk's

Tk

are

more

specificity.
dC

and Ara-T

similar

to

herpesvirus

in

substrate

They are less inhibited by dTTP, phosphorylate
and

can

utilize

CTP

as

a phosphate

donor.
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However, mitochondrial Tk's are strongly inhibited by dCTP.
The

low

substrate

specificity

of

herpesvirus

Tk

in

conjunction with the increased uptake of nucleosides imparts
the

herpesvirus

specificity

of

the

nucleoside

analog

antiherpetic agents such as acyclovir, 5-halogenated dC and
Ara-T.

Other large DNA viruses including Poxviridae (Esposito

et al., 1988; Boyle and Coupar, 1986; Barbanti-Brodano et al.,
1968; Kit et al, 1975) and Iridoviridae (Scholz et al., 1988;
Aubertine and Longchamps, 1974) also code for viral thymidine
kinases.

Poxvirus Tk is more similar to cytoplasmic Tk in

substrate specificity (Kit et al., 1975).
In the early 1980's there was a surge of interest in
viral thymidine kinase isozymes for use as selectable sites
of homologous recombination.

This enzyme is not essential for

viral replication and Tk negative mutants are resistant to Tk
activated,
gene

as

selection

antiviral agents.

a

site
of

of

foreign

recombinants

Therefore, the use of the Tk
gene
due

antiherpetic-resistant phenotype.

insertion
to

their

allows

rapid

Tk-negative,

In addition, Tk negative

mutants were found to be less pathogenic than the wild type
parent virus.

This gave impetus to the development of Tk

deletion and Tk based recombination systems for viral vaccine
vectors.

To use the Tk gene for recombinant experiments the

gene must first be located and cloned.

Thirteen herpesvirus

Tk genes have been cloned and sequenced.

When amino acid

sequences of herpesvirus Tk's are compared, only three small

regions of conservation can be located.
regions

Only one of these

show homology to the cytoplasmic and poxvirus Tk

sequences (Figure 1).

The amino acid sequences of the Tk's

have been valuable references
comparisons.

in herpesvirus evolutionary

These comparisons have led to the re-evaluation

of herpesvirus groupings.

For example, the turkey herpesvirus

and Marek's disease virus, once thought to be 7 herpesviruses
due to their lymphocyte specificity, are now considered more
related to a herpesviruses (Honess et al., 1989).

Table 1.

Characteristics of Thymidine kinase isozymes.

size (daltons)

inhibition

monomer
virus

active

HSV-1,
HSV-2,

41,000
41,000
35,000

70,000

40,000

85,000
83,000

vzv2i3

dTTP

ebv4

EHV-1s
EHV-3e
BHV-17
h vt 8
ILTVe
Mar HV9
HVS10
PRV,,
MDV,a
f h v ,3
BHV2,4
CMV
HV Aotus,,
Human C,,
M
Mouse C5
M

4 .

substrate
P acceptor
dCTP

low
low
low
low
low
low

low
low

low
low

low
low

low

dC

+
+
+
+
-

P donor
Ara-T

+
+
+
+
+

+
+

CTP

+
+
+
+
+

+
+
+

80,000
.
-

.

no thymidine kinase
no thymidine kinase
high
90,000
mod
.
high
mod

■

low
high

-

.

+

+

+

Jamieson and Subak-Sharpe. 1974. Doberson et al., 1976. Shiraki et al., 1985.
Turenne-Tessier et al., 1986. Allen et al., 1979. *McGowan et al., 1980.
7Weinmaster et al., 1982. *Kit et al., 1975. *Otsuka and Kit, 1984. ,0Honess et al„ 1982.
’’Leung et al., 1975. ,2Kit et al., 1974. **Nunberg et al., 1989. ’^Sheppard and May, 1989.

-

+
+
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Herpesviridae
HV Consensus
HSV-lj
HSV-22
Mar HV3
BHV-24
b h v -i 5

dG— G-GKtt*********EPm-YWr*********DRHp
DGphGmGKTT ******** *EPMtYWq* ********DRHP
DGphGvGKTT ******** *EPMtYWq* ********DRHP
DGphGvGKsT*********EPMaYWR*********DRHa
DGphGlGKTT*********EPMsYWs*********DRHP
DGahGlGKTT* ******* *EPMaYWR* ******* *DRHP
DGayGiGKTT*********EP1sYWR*********DRHP
DGayGtGKsT* ****** **EPMaYWR* ***** ***DRHP
DGayGiGKsl*********EPMlYWR*********DRHP
DGvyG iGKsT ******** *EPMaYWR* ******** DRHP
DGsmG iGKTs ******** *EPMkYWR* ******* *DRHP
DGpfGiGKTs*********EPMkYWR*********DRHP
eGapGvGKTT ******** *EPMrYWt********* DRH1
eGsiGvGKTT*********EPiaYWt*********DRHP

vzv 6
prv7

FHV8
EHV-ln
MDV 10
HVT 10
EBV 11
HSV 12

Poxviridae
vaccinia,,
f p v 14
s f v ;5
v a n o l a 16

iGpmfsGKsT
tGpxnfsGKTs
iGpmfaGKsT
iGpmfsGKsT

Vertebrate cytoplasmic
human17
chicken18
hamster19

Figure 1.
kinases.

IGpmf sGKsT
fGpmf sGKsT
lGpmfsGKsT

Amino

acid

sequence

homologies

among

thymidine

’Wagner et al., 1981 2Swain and Galloway, 1983 and Kit et al., 1983 JOtsuka and Kit, 1984 ^Sheppard and May. 1989
Mittal and Field, 1989 Davison and Scott, 1986 Kit, 1985aNunberg et al., 1989*Robertson and Whaley, 1988 Scott
et al., 1989 Baer et al., 1984 and Littler et al., 1986 Honess et al., 1989 ,3Hruby et al., 1983 ,4Boyle et al., 1987
Upton and McFadden, 1986 Esposito and Knight, 1984 Bradshaw and Deininger, 1984,4Kwoh and Engels, 1984
’’ Lewis, 1986.
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Chapter Two
Identification and Characterization of a Channel Catfish
Herpesvirus (CCV) Encoded Thymidine Kinase

Abstract
This
virus

investigation

(CCV)

encodes

demonstrated

a

thymidine

that

channel

kinase

(Tk)

catfish

which

is

biochemically distinguishable from the Tk of the host cell
line,

channel

catfish

herpesvirus Tk's.

ovary

(CCO),

as

well

as

other

A Tk deficient CCO cell line (CCOBr) was

developed by propagation in increasing concentrations of 5bromo-2'-deoxyuridine.
cells

produced

sensitive

to

high

the

Tk

CCV infection of the Tk deficient
Tk

activity.

activated

arabinofuranosylthymine

(Ara-T).

CCV

was

found

antiherpetic

agent,

A mutant of CCV

to

1-6-D

(CCVAr),

isolated by serial passage in BUdR followed by Ara-T,
found to be resistant to Ara-T and Tk negative.

be

was

Extracts of

CCO and Tk negative cells infected with CCV were assayed for
differences in competitive inhibition, thymidine triphosphate
(dTTP)

mediated

specificity.
deoxypurines

feedback

CCV-Tk was
than

feedback inhibition.

CCO-Tk

inhibition

and

phosphate

more

competitively

and

showed

less

donor

inhibited by
dTTP

mediated

CCV-Tk was unique among herpesvirus Tk's

in it's inability to utilize CTP as a phosphate donor.
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Introduction
Thymidine kinase (Tk) phosphorylates thymidine (dT) into
thymidine monophosphate (dTMP). This reaction is part of the
salvage pathway for producing thymidine triphosphate (dTTP),
a necessary precursor for DNA synthesis.

The Tk gene is a

normal component of cells and many large DNA viruses, yet it
is not essential under normal culture conditions because the
cell

can

rely

on

de-novo

dTTP

synthesis,

where

dTTP

produced by methylation of deoxyuridine monophosphate.

is

As a

result the Tk gene can be used as a doubly selectable marker
for genetic recombination experiments.
positive

cells

and

viruses

can

grow

If supplied dT, Tk
in

the

presence

aminopterin, an inhibitor of de-novo dTTP synthesis.

of

On the

other hand,

Tk negative mutants can be selected by their

resistance

to

toxic

bromo-2'-deoxyuridine

thymidine

analogs,

(BUdR), which

mediated phosphorylation.

are

such

activated

as
by

5Tk

In addition, herpesvirus isozymes

are often less specific than cellular Tk, resulting in the
selective antiherpetic action of nucleoside based antiviral
agents

such

as

1-B-D

arabinofuranosythymine

(Ara-T)

9- (2-hydroxyethoxymethyl) guanine (acyclovir).

and

These agents

are first phosphorylated by the viral Tk and then cellular
enzymes

phosphorylate

triphosphate

compounds

the
that

monophosphate
interfere

compounds

with

viral

to
DNA
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synthesis.
Tk

based

selection

has

greatly

facilitated

molecular dissection of mammalian herpesviruses.

the

Herpesvirus

Tk genes have been used as reporter genes to analyze promoter
elements (Pater and Pater, 1984).
used in
sites

Also, Tk genes have been

homologous recombination experiments as selectable

for

the

insertion

of

foreign

genes

(Mocarski

et

al.,1980) and as selectable insertion sequences to interupt
other viral genes (Post and Roizman, 1981).
Previous work by others

(Buck and Loh,

1979) indicated that CCV may encode its own Tk.

1985: Huston,
The purpose

of this investigation was to confirm the presence of a CCV
encoded Tk, clearly distinguish it from cellular Tk and to
develop Tk deficient

mutants of CCV and the host cell for

future marker-rescue based Tk gene mapping.

Materials and Methods
CCO cells were routinely grown in Dulbecco's modified
minimal essential medium (DMEM) supplemented with 10% fetal
calf serum, 25 mM HEPES buffer and 50 jug/ml gentamycin or 100
IU/ml penicillin and 100 /ig/ml streptomycin.

The mutation and

selection of Tk deficient CCO cells was done by passage in
medium containing increasing levels of BUdR: 5 mg/1 for 23
passes, 50 mg/1 for 21 passes, 150 mg/1 BUDr for 7 passes, 250
mg/1 for 2 passes and 500 mg/1 for 8 passes.
The CCV used in this experiment was the ATCC type strain
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(Auburn

clone A) .

The

sensitivity

of

CCV

to Ara-T

was

determined by comparing the median tissue culture infective
dose

(TCID 50)

of a viral

suspension

in ten

fold serial

dilutions of 1 mM Ara-T to non-exposed controls.

An Ara-T

resistant CCV mutant was selected by passage of the virus in
the presence of 20 mg/1 BUdR, followed by 50 mg/1 BUdR and 0.1
mM Ara-T and finally by dilution cloning three times in 0.1
mM Ara-T.
Cell

extracts

for

Tk

analysis

were

prepared

from

confluent cell sheets in 150 cm2 tissue culture flasks by
rinsing the cells with Hank's balanced salt

solution and

scraping

lysis

the

cells

into

2 ml

of

ice

cold

buffer

containing 10 mM tris (pH 7.5), 10 mM KC1, 1.5 M MgCl2, 0.1 mM
phenyl-methylsulfonyl

flouride

(PMSF).

Unless

otherwise

specified, viral Tk extracts were prepared in a similar manner
from confluent Tk negative cells infected with 0.1 plaque
forming unit (PFU)/cell, and incubated 18 hours at 30 C.
cells were lysed by freeze-thawing two times,

The

followed by

sonication on ice on a Branson Sonifier (Cell Disrupter 200)
using a microtip with a 50% interval setting at power level
6 for 30 seconds.
50% glycerol,

The lysate was then mixed with 200 /nl of

1.5M KC1,

12.5mM MgCl2, 3mM 2-mercaptoethanol

(2ME) and cleared by centrifugation at 100,Q00g for one hour
at 4 C.

The cleared lysates were stored for a maximum of

three weeks at -70 C for use in Tk assays.
The Tk activity was determined by quantifying the amount

of tritium labeled thymidine
extracts.

Basically,

reaction solution

equal

(3HdT)

phosphorylated by

volumes

of

cell

(10.6 mM MgCl2, 8 mM KCl,

extract

the
and

120 mM Tris pH

8.0, 0.5 mCi/ml 3HdT, 20 mM ATP, 10 mM NaF, 0.16 mM 2ME) were
combined,
mixture

incubated at 27 C for 3 hours and

was

spotted

on

a

1 cm2 DEAE

paper

20 fil of the
square.

The

negatively charged 3HdTMP bound to the cationic substrate and
the unphosphorylated 3HdT was washed off the paper by rinsing
it three times in 4 mM ammonium formate pH 3.6, three times
in distilled water, once in 95% ethanol and once with 100%
ethanol.

The paper squares were dried at 60 C for two hours,

and the bound 3HdTMP quantified by liquid scintillation.

In

all assays 1 mg/ml bovine serum albumin (BSA) was used as a
negative control.

Variations of the above protocol included

the addition of 0.5, 0.05 or 0.005 mM final concentration of
BUdR, Ara-T, dT, deoxyadenosine (dA), deoxycytosine (dC), or
deoxyguanosine

(dG) to the reaction mixture for competitve

inhibition assays, the addition of 0.5, 0.05 or 0.005 mM final
concentration of deoxythymidine triphosphate
reaction mixture

for

feedback

inhibition

(dTTP)

assays,

to the
and

the

replacement of the 10 mM ATP with 0.5, 1.5, 4.5 or 13.5 mM
final concentration of ATP or cytosine triphosphate (CTP) for
phosphate donor assays.
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Development of Tk deficient CCO cells.
Normal CCO cells die when cultured in the presence of 25
mg/1 BUdR within seven passes.

However, after 23 passes in

5 mg/1 BUdR the cells could be continuously cultured in 50
mg/1

BUdR.

After

21

passes

in 50 mg/1

BUdR,

the

cells

retained a relatively high Tk activity (8270 cpm) compared to
normal

CCO

extracts

(14,850

cpm).

Cells

that

were

successively cultured in 150 mg/1 BUdR, 250 mg/1 BUdR and 500
mg/1 BUdR were resistant to 500 mg/1 BUdR

(CCOBr)

and had

significantly reduced Tk activity when compared to normal CCO
cell extracts (Figure 1).
High Tk activity was
infected with CCV

found in the Tk negative cells

(Figure 1) .

Tk activity was highest 16

hours after infecting CCOBr cells with one plaque forming unit
per

cell

(figure

2) , at

which

time

the

cell

sheet

was

characterized by total involvement of the cells in syncytia
(4+ cytopathic effect).

Sensitivity of CCV to Ara-T and development of a resistant
mutant.
The infectivity of CCV was reduced 1000 fold in 10'6 M
Ara-T and was completely eliminated in 10"4 M Ara-T (Figure 3) .
The sensitivity of CCV to the Tk activated, antiherpetic agent
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20

10

-

CPM

( thousands)

15 -

5 -

CCO

CCOBr

CCV

CCVflr

Tk extract

Figure 1.
Tk activities of CCO cells, CCOBr cells, CCV
infected CCOBr cells and CCVAr infected CCOBr cells
(mean+SD). The reactions were run using three extracts
from each Tk type prepared from 25 cm flasks in a total
volume of 300 pi.
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( thousands)

40
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CPM

20
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0
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4

8

12

Hours post

infection

16

Figure 2. The elevation of Tk activity in CCOBr cells
infection progresses. CCOBr cells were infected
PFU/cell and sampled at 0, 2, 4, 8, 10, 12.5, 16
hours post infection.
All samples were diluted
#zg/ml total protein, and incubated at 25 C for 12

20

as CCV
with 1
and 18
to 700
hours.

log

TCID50/ml

CCV
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log molarity of flraT

Figure 3. Effect of Ara-T
culture was dilution
in medium containing
The tissue culture
calculated using the

on infectivity of CCV. A stock CCV
plated on CCO cells and incubated
ten fold dilutions of 1 mM Ara-T.
infective doses (TCID 50) were
methods of Reed and Meunch (1938).
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Ara-T,

combined with the

deficient

cells,

Subsequent
Ara-T

indicates

induction of Tk activity
that

CCV

contains

a

Tk

in Tk
gene.

passage of the virus in the presence of BUdR and

resulted in selection of an Ara-T resistant mutant of

CCV (CCVAr).

This mutant virus replicated efficiently in Tk

negative cells,
(Figure

l) .

yet did not induce detectable Tk activity

Therefore,

CCVAr was considered a thymidine

kinase deficient CCV mutant.

Characterization of cellular and viral isozvmes
The cellular and viral induced Tk isozymes were compared
by assessing the nucleoside competitive inhibition profiles,
ATP and CTP phosphate donor specificity,
feedback inhibition.
competitive

and dTTP mediated

Unlabelled dT, used as a reference for

inhibition

comparisons,

produced

significantly

different inhibition profiles for each isozyme
indicating different enzyme kinetics.
alternate

substrate

competitive

(Figure 4) ,

Therefore, to simplify

inhibition

analyses,

the

relative percent inhibition by each substrate was determined
by dividing the inhibition induced by the inhibition induced
by a similar level of dT (Figure 5) . CCO-Tk and CCV-Tk showed
similar competitive inhibition profiles for dC.
BUdR induced inhibition of each

Ara-T and

isozyme was statistically

different, but quantitatively similar.

The viral Tk was much

less specific for the deoxypurines dA and dG than the cellular
Tk.
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percent

Tk

activity

CCV

CCO

0.0!

0.10

0.60

dT concentration (mM)

Figure 4. Competitive inhibition of 3HdT phosphorylation by
unlabelled dT.
Values are expressed in percentage of
maximum activity.
Statistics were performed using the
Student's T test on arcsin of the square root transformed
data
to
account
for
non-normal
distribution
of
percentage values.
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90
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of dT
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percent

inhibition
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40

50
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20
10

0

0
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flra-T

0

V

BUdR

0

V

dC

0

V

dR

0

V

dG

Figure 5. Relative competitive inhibition of Tk mediated 3HdT
phosphorylation by thymidine analogs and deoxynucleosides
in CCO-Tk extracts (O) and CCV-Tk extracts (V). Values
are expressed in percentage of the inhibition induced by
a similar concentration of dT. Statistics were performed
on SAS using the Student's T test on arcsin of the square
root transformed data
to account
for non-normal
distribution of percentage values.
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Feedback inhibition was more pronounced in the CCO Tk
than CCV Tk at all

levels

od dTTP concentration and was

statistically significant at 0.5 mM dTTP (Figure 6).

Both

isozymes were inefficient at using CTP as a phosphate donor.
Also, phosphate donor assays showed that the cellular enzyme
required lower levels of ATP to reach peak Tk activity than
the viral isozyme (Figure 7).

Discussion
The
research

Tk
was

deficient

CCO

pivotal

in

cell

line

established

determining

characteristics of the CCV expressed Tk.

the

in

this

presence

and

The CCOBr cell line

had approximately 10% of the Tk activity of the normal CCO
cells.

A low residual Tk activity due to mitochondrial Tk

activity is common among BUdR resistant cell lines
al., 1973a; Kit et al., 1973b).

(Kit et

The apparent initial BUdR

resistance of the CCO cells that maintained high Tk activity
while being continuously cultured

in 50ug/ml

BUdR may be

explained by a mutation in the thymidine transport system
similar to a mutation described in 3HdT resistant Chinese
hamster cells (Breslow and Goldsby, 1969).

Increasing the
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acti v ity

CCV

percent

CCO

o.oi

o.io

0.60

dTTP concentration (mM)

Figure 6. A comparison of dTTP feedback inhibition of CCO-Tk
and CCV-Tk.
Values are expressed as a percentage of
maximum activity.
Statistics were performed using the
Student's T test on arcsin of the square root transformed
data
to
account
for
non-normal
distribution
of
percentage values.
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activity
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of maximum

CCV-RTP

CCO-CTP
CCV-CTP,

0

10

20

phosphate donor concentration (mM)

Figure 7. CTP and ATP phosphate donor specificity of CCO-Tk
and CCV-Tk. Values are expressed in percentage of
maximum activity.
Statistics were performed using the
Student's T test on arcsin of the square root transformed
data
to
account
for
non-normal
distribution
of
percentage values.
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BUdR

levels

to

500/ig/ml

probably

induced

an

additional

mutation making the cell Tk deficient.
The induction of high Tk activity in CCOBr cells by CCV
and the production of a mutant virus which does not have a Tk
inducing activity indicates CCV encodes a thymidine kinase.
Only

2

of

17

herpesviruses

analyzed

to

date,

the

human

cytomegalovirus and herpesvirus aeotus, do not contain a Tk
gene.

Generally

herpesvirus

Tk's

have

less

restricted

substrate specificity and dTTP feedback inhibition than the
cell's

cytoplasmic

Tk.

The

phosphate

donor

specificity,

competitive inhibition and dTTP mediated feedback inhibition
assays used in this investigation clearly distinguished the
cellular Tk from the CCV Tk.
were

used

as

indicators

direct measurement

of

Competitive inhibition assays

of

substrate

alternate

specificity

substrate

because

phosphorylation

would require significant enzyme purification to discount the
effects of other enzymes.

Competitive inhibition profiles

indicate which substrates bind to the active site and block
Tk activity,

but do not

indicate whether the

substrate is phosphorylated.

alternative

These investigations showed that

the cellular Tk used low levels of ATP more

efficiently,

exhibited different enzyme kinetics as indicated in the dT
inhibition

profile,

was

not

competitively

inhibited

by

deoxypurines and was more inhibited by dTTP than the viral Tk.
The ATP and dT profiles indicate cellular Tk has a lower
processivity and a higher substrate binding activity than the

viral enzyme, making it most efficient in conditions of low
substrate

concentrations.

The

cellular

Tk

competitive

inhibition profiles for Ara-T and dC were high compared to the
profiles

for

bovine,

equine,

rabbit,

mouse

and

human

cytoplasmic Tk (Turenne-Tessier et al., 1986; Kit and Qavi,
1983; McGowan et al., 1980; Allen et al., 1979), indicating
that

catfish

mammalian Tk

cytoplasmic

Tk

may

be

less

specific

and may be a more primitive enzyme.

than

The most

distinctive feature of the CCV-Tk was its strong competitive
inhibition by

deoxypurines,

especially

dG.

The moderate

specificity of the cellular Tk to Ara-T and dC in conjunction
with

the

selective

viral

Tk

inhibition

by

deoxypurines

indicate that deoxypurine analogs such as acyclovir may be
more selective antiviral agents for CCV than deoxypyrimidine
analogs such as Ara-T or Ara-C.

CCV-Tk was similar to other

herpesvirus Tk's in nucleoside competitive-inhibition profiles
and low dTTP inhibition but was unusual in it's low efficiency
in

using

CTP

as

a

phosphate

donor.

The

Tk's

of

other

herpesviruses such as herpes simplex 1 and 2 (Kit et al.,
1975),

Epstein-Barr virus

(Turenne- Tesner et al.,

1980),

equine herpesvirus 1 (Weinmaster et al., 1982), herpesvirus
of turkeys and infectious laryngotracheitis virus (Kit et al.,
1975), characteristically use CTP effectively as a phosphate
donor.

In this respect CCV-Tk is more similar to poxvirus and

cytoplasmic cellular Tk (Kit et al., 1975).
This investigation demonstrated that CCV encodes a unique

Tk which is clearly distinguishable from cellular Tk activity.
It

also

indicated

that

the

CCV-Tk

has

phosphate

donor

specificity that is unique among herpesvirus Tk's, which, in
conjunction with the evolutionarily distant nature of the
host, would make the CCV-Tk gene sequence a uniquely valuable
reference to compare with higher

vertebrate herpes Tk gene

sequences for enzyme and herpesvirus evolution studies.

In

addition the sequence could be a key reference in studying the
structure function relationships in the herpesvirus Tk group.
Research

is currently underway using the thymidine kinase

deficient, CCVAr mutant in marker-rescue assays to locate the
Tk gene on the CCV genome for subsequent sequence analysis.
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Chapter Three
The Channel Catfish Herpesvirus (CCV) Thymidine Kinase Gene
is Located in The Terminal Direct Repeat Regions of the Genome

Abstract
The

gene

encoding

the

channel catfish herpesvirus

previously

identified

unique

(CCV) thymidine kinase (Tk) was

preliminarily located on the CCV genome.

CCV genomic DNA

libraries were constructed into plasmid pUC 19 and cosmid pHC
79.

Analysis of CaCl2, DEAE and cationic liposome mediated

transfection techniques using /3-galactoside expressing plasmid
pON 105 on the channel catfish ovary cell line (CCO) , a Tk
deficient mutant of CCO (CCOBr), and the brown bullhead cell
line (BB) revealed cationic liposome transfection of CCO cells
to be most effective combination.

More importantly, cationic

liposome mediated transfection of whole CCV-DNA onto CCO or
CCOBr cells was the only method that effectively produced
infectious viral progeny.

This is the first account showing

purified CCV-DNA to be infectious.

Subsequently,

cationic

liposome mediated co-transfection of cloned wild type CCV DNA
with the Tk deficient mutant of CCV (CCVAr) in marker rescue
assays, mapped the mutation within the 18 Kb direct repeat
59
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ends

of

the

reaction,

genome.

In

addition,

the

polymerase

chain

(PCR), was used (Jack Numberg, Cetus Corporation)

to amplify regions

flanked by

degenerate

corresponding

sequences

primers
among

herpesvirus

sequences with homology to
to

conserved

Tk's.

Three

amino

PCR

acid

generated

fragments were isolated, cloned into pUC 19 and sequenced.
The

corresponding

amino

acid

sequence

of the

presumptive

coding strand of one sequence (405) showed limited homology
to the mammalian cytoplasmic and poxvirus Tk.

A weak specific

hybridization signal was located on the Eco RI L fragment,
which is located on the direct repeat ends of the CCV genome,
when DNA-DNA hybridization analysis was performed using the
purified

32P nick-translation

labelled

405

fragment.

The

combined marker rescue and PCR data map the Tk gene within the
direct repeat region of the CCV genome.

This location is

unique among herpesviruses, indicating significant divergence
from previously identified herpesvirus gene arrangements.

Introduction
Because

thymidine

readily detectable,

kinase

(Tk),

is

a

non-essential,

selectable trait in herpesviruses,

the

herpesvirus Tk genes have been the center of much recombinant
molecular virology research.

Herpesvirus Tk genes have been

used as selectable sites of homologous recombination to insert
foreign

genetic

material

(Mocarski

et

al.,

1980),

as
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selectable insertion sequences to interupt other genes (Post
and Roizman,

1981),

as reporter genes to analyze promoter

elements (Pater and Pater, 1984) and as reference sequences
for evolutionary comparisons (Honess et al., 1989).

Also, Tk

deletion mutants have been used as permanently attenuated live
vaccines.
Recent mutagenesis and enzyme substrate specificity data
indicate

that

channel

catfish

virus

herpesvirus 1) contains a Tk gene

(CCV)

(Ictalurid

(Chapter Three)

that is

unique among herpesviruses in it's inability to utilize CTP
as a phosphate donor.
unique

enzyme

previously

The evolutionarily distant host and

characteristics

analyzed

of

herpesviruses

this
Tk's

Tk
make

compared
this

to

gene

a

valuable reference for evolutionary and structure function
comparisons.

In

addition,

Tk

negative

mutations

in

herpesviruses generally attenuate the pathogen making them
suitable

as

live

vaccine

agents.

The

purpose

of

this

investigation was to map the viral Tk gene on the CCV genome
for future evolutionary comparisons and vaccine development.

Materials and Methods
Channel
Dulbecco's

catfish
modified

ovary

cells

minimal

(CCO)

essential

were

grown

medium

in

(DMEM)

supplemented with 10% fetal calf serum, 25 mM HEPES buffer and
100

IU/ml

penicillin

and

100

ng/ml

streptomycin

(growth

medium). The Tk negative mutant of CCO (CCOBr)(Chapter 3) was
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maintained in growth medium supplemented with 500 MS/ml of 5bromo-2'-deoxyuridine (BUdR).

The CCV strains used in this

experiment were the ATCC type strain (Auburn clone A) and a
Tk negative mutant of this strain, CCVAr (Chapter 3).
Stock virus was produced by infecting CCO cells with 0.01
plaque forming units per cell, disrupting the cell sheet after
18 hours at 30 C, freeze thawing the suspension two times and
storing aliquots at -70 C.

Stock CCVAr was produced under

similar conditions except for the presence of 0.1 mM Ara-T in
the growth medium.

Concentrated virus for DNA isolation were

produced from roller bottle cultures of CCO cells.

Infected

cells were dislodged from the bottle and centrifuged at 500g
for

5 minutes

at

4

C.

The

supernatant

containing

the

extracellular virus was saved and the pellets were resuspended
in TNE buffer (10 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, pH 7.5)
and lysed by one cycle of freeze thawing, followed by dounce
homogenization.

The cellular debris was again centrifuged at

3000g for 15 minutes at 4 C and the supernatent containing the
intracytoplasmic

virus

was

pooled

with

the

extracellular

virus. The pooled virus was pelleted from the medium at 18,000
g for one hour at 4 C.
Concentrated virus from 8 roller bottles was purified on
20 to 60% sucrose gradients at 26,000 rpm in a Beckman SW27
rotor for 1 hour at 4 C using tritiated thymidine labelled
virus as a tracer.

For library construction,

purified from fractions containing high counts.

CCV-DNA was
The fractions
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were digested with 5 fig/ml DNase free RNase, 5^g/ml proteinase
K

in

0.5%

SDS

at

45

C

for

4 hours,

followed

by

gentle

extraction two times with two volumes of 50 mM Tris, pH 8.0,
1 mM EDTA saturated, buffered phenol and three times with
water saturated ether.

Residual ether was driven off the

solution at 70 C for 15 minutes.

This solution was dialyzed

in three changes of TE buffer (10 mM Tris-HCL, 1 mM EDTA, pH
8.0) at 4 C.

Purity of concentrated CCV-DNA was checked by

agarose gel electrophoresis of Eco RI digested fragments, and
only fractions producing clean distinct Eco RI restriction
fragments

of

CCV

were

used

for

subsequent

library

construction.
Infectious

CCVAr-DNA

gradient centrifugation.
4 roller bottles

was

purified

by

sodium

iodide

The total concentrated virus from

were suspended in 15 ml of TNE and digested

with RNase and proteinase K in SDS as described above.

This

suspension was added to 24 mis of Nal saturated TE buffer
containing 0.3 mg ethidium bromide and centrifuged at 48,000
rpm for 40 hours at 20 C in a Beckman VTi 50 rotor.

The

distinct viral DNA band was visible under long wave UV light,
and was gently harvested using a syringe with a 14 gauge
needle,

gently

extracted

with

isobutanol

to

remove

the

ethidium bromide, and dialyzed in TE buffer.
An

incomplete

genomic

library

of

CCV

was

made

by

digesting purified viral DNA to completion with Eco RI and
'shotgun'

cloning these fragments into the Eco RI site of

plasmid pUC-19.

The recombinant plasmids were transformed

into DH5a E^_ coli using the calcium chloride method of Hanahan
(1983).

Transformants were

isolated on

LM

agar medium

containing 50 /xg/ml ampicillin and coated with 2 ng of X-gal.
White colonies, indicative of transformants containing

pUC-

19 with an

were

insertion

subcultured.

in the Lac

Z polylinker

site,

The respective plasmids were purified using a

rapid plasmid isolation procedure (Holmes and Quigley, 1981)
and then cut with Eco RI.

These DNA fragments were analyzed

by agarose gel electrophoresis.
DNA

fragments

were

compared

The size of inserted viral
to

the

published

Eco

RI

restriction map (Chousterman et al., 1979) to determine its
location on the genome.
A more complete genomic library of CCV was produced by
cloning a partial Eco RI digest of viral DNA into the cosmid
pHC-79.

First, 12 jug of CCV DNA was digested with 2.4 units

of EcoRI for 60 minutes in 30 jul at 37 c and 3.6 jug of this
DNA

was

mixed

with

0.35

jug of

calf

intestine

alkaline

phosphatase-dephosphorylated Eco RI digested pHC-79 DNA.

The

DNA mixture was ethanol precipitated, reconstituted to 10 jul
and ligated.
(1982).

This methodology was similar to Maniatis et al.

The ligation mixture was subsequently packaged into

X capsids

(Stratagene,

Gega Pack Gold,

transfected into DH5a E^. coli.

La Jolla,

CA)

and

Transformants were selected

on ampicillin plates and the inserts were analyzed by Eco RI
digestion

followed

by

agarose

gel

electrophoresis.

The

65

corresponding location of the cloned fragments on the CCV
genome were determined by comparing the Eco RI electrophoretic
profile

to

the

published

Eco

RI

restriction

map

of

CCV

(Chousterman et al., 1979).
A

comparison

of

CaCl2,

DEAE

and

cationic

liposome

mediated transfection methods on CCO, CCOBR and brown bullhead
(Ictalurus nebulosis) (BB) cell lines at 60 to 80% confluency
in 6 well plates was performed using the plasmid pON 105 which
contains the E. coli lac Z gene under the control of the
herpesvirus simplex virus (HSV) immediate early promoter from
the IE 4 gene

(Ho and Mocarski,

1988) .

At 72 hours post

transfection cells were fixed in 0.5% glutaraldehyde in PBS
for 15 minutes, rinsed three times with PBS (137 mM NaCl, 2.7
mM KC1, 4.3 mM HP04.7H20, 1.4 mM KH2P04, pH 7.4) then stained
in a solution of 2.4 mM X-gal, 12.5 mM K3Fe CN6, and 12.5 mM
K4FeCN6.3H2Q

in

PBS

overnight.

/9-galactosidase

(B-gal)

positive transfected cells stained blue and were counted in
7 fields of view at low power on an inverted microscope (12
mm2/view).

The mean counts of positive staining cells per

view were divided by the mean number of cells in the viewing
area to determine the transfection efficiency.
The

CaCl2

mediated

transfection

procedures

were

modifications of Ausubel et al. (1987) . First, 7 /xg of DNA and
7

of 2.5 M CaCl2 were mixed and diluted to 60 jul with

distilled water.

Sixty /xl of 2X BBS was slowly added under

constant agitation.

This mixture was held at room temperature
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for 20 minutes,

diluted with

dispersed over the cells.

3 ml

of growth medium,

and

Cells were incubated 4 to 5 hours

at 30 C, shocked for 3 minutes with 15% glycerol or 25% DMSO
in TBS,

rinsed with TBS and overlayed with growth medium.

Modifications

of

the

above

pretreatment,

in

which

the

procedures
cells

were

included
rinsed

a

DEAE

with

TBS,

overlayed with 1.5 ml of 500 /ug/ml DEAE dextran (MW 500,000)
for 3 minutes and rinsed with TBS before the CaCl2 precipitate
overlay,

or a 100 jiM chloroquine treatment during the the

incubation with the CaCl2 precipitate.
DEAE dextran transfection procedures followed the methods
of Ausubel et al.(1987).

The cells in each well of a 6 well

plate were rinsed three times with serum free medium (SFM) and
overlayed with a mixture of 200 /xg DEAE dextran and 2.5 /xg DNA
in 1 ml of SFM.
glycerol

or

DMSO

After four hours, the cells were either
shocked

as

previously

described.

A

modification of the above procedure was the addition of 100
juM Chloroquine to the treatment mixture.
Cationic liposome mediated transfections were performed
using the Lipofectin reagent (Bethesda Research Laboratories,
Bethesda,

MD)

according

to

the

methods

described

by

the

manufacturer or by method C of Feigner and Holm (1989).
Marker rescue assays were performed using cationic liposome
mediated co-transfection of CCVAr-DNA and cloned CCV-DNA by
a modification of transfection method C of Feigner and Holm
(1989).

Basically, 50 to 70 % confluent CCO cells in a 25 cm2
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tissue culture flask were rinsed 3 times with 1.5 ml of serum
free

growth

medium

(SFM)

and

overlayed

with

containing 50 ng Lipofectin for 30 minutes.

1.5

ml

SFM

Subsequently,

1.5 ml of SFM containing 5 fig CCVAr DNA and 7 ng cloned CCVDNA was added and incubated at 30 C
3

ml

of

growth

medium

for 20 hours, after which

containing

20%

FCS

was

added.

Cytoplasmic effect (CPE) was usually evident 4 days later, and
virus was harvested when CPE

covered the entire cell sheet.

Tk marker rescue was identified by plating the virus on
CCOBr cell monolayers on single well glass slides using the
Tk plaque autoradiography method of Tenser et al. (1983).

The

percentage of recombinants were scored by placing the slide
on the autoradiograph and comparing the number of plaques with
a black background

to

the

number

of plaques

on

a

light

background under a dissecting microscope.
Purified CCV-DNA was used in PCR by Dr. Jack Nunberg
(Cetus Corporation) to amplify regions flanked by sequences
with homology to degenerate primers corresponding to conserved
amino acid sequences among herpesvirus Tk's using the primers
and methods

previously

described

(Nunberg et

al.,

1989).

Herpes simplex virus type 1 (HSV-1) and feline herpesvirus l
(FHV-1) DNA were used as positive controls.
were

phenol-ether

extracted,

ethanol

The PCR products
precipitated

and

resuspended in 30 Ml of 5 mM Tris (pH 8.0), 0.1 mM EDTA.

Ten

Ml of each product was separated by vertical 5% polyacrylamide
gel electrophoresis (PAGE) and stained in 0.5

m 1/ml

ethidium

bromide.

Bands of apoproximately 330 bp (co-raigrating with

HSV-1 and FHV-1 Tk specific bands) from CCV PCR products were
ecxised and placed in 0.5 ml of 0.5 M ammonium acetate for
elution as described by Maniatis et al.

(1982).

The eluted

PCR fragments were Eco RI and Hind III digested and cloned
into Eco RI, Hind III cut pUC 18 (purified from the polylinker
fragment by low melt agarose electrophoresis and phenol ether
extraction) .

Plasmids were

isolated

from /3-galactosidase

negative transformed colonies using the rapid purification
method described above, digested with Eco RI and Hind III, and
analyzed by 5% PAGE.

Large scale plasmid extracts were made

of three clones (405, 409 and 398) containing Eco RI/Hind III
restriction fragments of the proper size and purified by CsCl2
gradient centrifugation (Maniatis et al., 1982).
The inserts of purified plasmids were double stranded,
dideoxyribonucleotide
sequencing

kit

Corporation,

sequenced using a T7

(Sequenase

Cleveland,

2.0,

United

DNA polymerase

States

Biochemical

OH) with M13 positive and negative

strand primers and a35SATP (1000 Ci/mM) as a label according
to the manufacturers methods.
electrophoresed on
urea

gels

(Gel-Mix

The reaction mixtures were

35 X 60 cm X 0.4 mm, 6% polyacrylamide6,

Bethesda

Bethesda, MD) at 200 W, 55 C.

Research

Laboratories,

The gels were dried onto paper

supports and autoradiographed at room temperature for two days
using XAR-5 film (Kodak, Rochester, NY).
DNA-DNA

hybridization

analyses

of

Eco

RI

cut,

0.7%

agarose gel electrophoresed CCV and cosmids 395, 394, 389, 388
DNA were performed using 32P labelled purified
plasmids

405

and

electrophoresed

at

409

as

probes.

1 v/cm

The

overnight,

inserts of

agarose

gels

were

then vacuum blotted

(Trans-vac, Hoeffer Scientific, San Fransisco, CA) onto Gene
Screen Plus (DuPont Inc., Boston, MA) nylon membranes using
the methods described by Sambrook et al.

(1989).

The PCR

derived inserts were excised from plasmids 409 and 405 by Eco
RI and Hind III digestion, purified by 5% PAGE and eluted in
sodium acetate buffer as described earlier.

Approximately 7

ng of each insert were nick translation labelled with a32PCTP
using the kit NEK-004 (Dupont, Boston, MA) and purified using
a sephadex G25 spin column.

The blots were prehybridized in

50% formamide, 10% dextran sulfate, 1% SDS, 1 M NaCl and 0.2
/xg/ml denatured salmon sperm DNA at 42 C for 2 hours followed
by hybridization at 45 C overnight using one half of the heat
denatured probe in 10 ml of prehybridized solution.

The blots

were then washed two times in 2X SSC (3 M NaCl, 0.03 M sodium
citrate, pH 7) at 65 C for 15 minutes, rinsed in SSC, wrapped
in plastic film and autoradiographed with Kodak XAR-5 film at
70 C using intensifying screens.

Results
The genomic library developed in pUC19 was incomplete
because several large fragments, specifically A, C and F, were
resistant to cloning after several attempts.

A more complete
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library was constructed using the cosmid pHC79 system because
of

it's

selectivity

for

larger

DNA

inserts.

Sixteen

ampicillin resistant transformant colonies were analyzed and
all contained cosmids with 30 to 40 Kb viral DNA inserts.
Four unique clones, covering 98% of the genome, were selected
for the initial marker rescue assays (Figure 1).
The

most

transfecting

CCV

efficient
permissive

and

reproducible

cell

lines

was

method
the

of

cationic

liposome mediated technique of Feigner and Holme (1989) . This
method produced

0.1%

transfectants

in CCO and CCOBr cell

lines, which was a 10 to 200 fold higher frequency than the
various CaCl2 and DEAE mediated transfection techniques.
cell

transfection

experiments

consistently

BB

produced

transfection efficiencies at least 10 fold lower than the
respective CCO and CCOBr transfection experiments.
attempts

to

produce

infectious

progeny

transfection of CCV-DNA were unsuccessful.

by

Early

CaCl2 mediated

However, the first

cationic liposome mediated transfection of CCOBr cells with
10

ij,
g

of

CCV-DNA

produce

infectious

CCV

progeny.

In

subsequent marker rescue assays using CCVAr-DNA, infectious
progeny were produced 80% of the time.
Of the four initial cosmids used in marker rescue assays,
both end cosmids 395 and 389 rescued the CCVAr mutation very
efficiently. Cosmid 395 induced 67% rescue and 389 induced 82%
rescue, while cosmids 388 and 394 produced no detectable

CO O)
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Figure 1. A. Agarose gel electrophoretic profile of Eco RI digested cosmids containing the
CCV DNA inserts used in marker rescue experiments. The letters on the left designate the
Eco RI fragments as defined by Chousterman et al., (1979). The right lane contains Hind III
digested bacteriophage A DNA as size markers, the corresponding sizes in Kb are designated
adjacent to this lane.
B. Location of the CCV DNA inserts of the cosmids in A on the Eco
RI restriction map (Chousterman et al., 1979).
1
~
C. 14CdT autoradiograph analysis of viral
plaques from rescue experiments.

vj
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rescue (<0.1%).

Cosmids 395 and 389 contain DNA from opposite

ends of the genome and thus contain common sequences from the
terminal

direct

repeat

region.

Subsequently,

cosmids

overlapping the CCV unique portion of cosmid 395, 383 and 386
(Figure 1), were used in marker rescue and were also found to
be negative.
Three PCR generated fragments that were produced using
degenerate Tk primers were cloned into pUC 18 and sequenced.
The sequence of one fragment (409) corresponded to the FHV-1
Tk gene and was probably a contaminant generated by the PCR
reaction

or

isolated

purification.

by

cross

contamination

during

PAGE

The corresponding amino acid sequences of the

presumptive coding strand of fragment 389 showed no homology
to published Tk sequences and contained several stop codons.
The deduced amino acid sequence of the presumptive coding
strand of fragment 405 (Figure 2) showed limited homology to
vertebrate cytoplasmic and poxvirus Tk sequences (Figure 3).
Hybridization

analyses

electrophoresed
fragments

409

CCV
and

and
405,

of

Eco

cosmid
showed

RI

digested,

DNA
some

using

agarose
PCR

specific

gel

generated
binding

of

fragment 405 to the Eco RI K, L fragments of CCV and the Eco
RI fragment of cosmid 389 (Figure 4).
homology to viral sequences.

Fragment 409 showed no
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Discussion
This investigation showed that CCV-DNA is infectious,
established a method for marker rescue analysis of CCV and
mapped the Tk negative mutation in CCVAr to the terminal
direct repeat regions of the CCV genome.
the Tk gene, the Tk of CCV is diploid.

If this represents
This diploid nature

would explain the very high percentages of rescue found with
cosmids 389 and 395 because only 1 of the 2 genes in the
genome would
phenotype.

need to be rescued to impart a Tk positive

A Tk gene located in the repeat regions is unique

among the herpesviruses thus far investigated.
1 and 2

(Wagner et al.,

psuedorabies virus

1981;

Herpes simplex

Swain and Galloway,

1983),

(Kit, 1985), bovine herpesvirus 1 and 2

(Mittal and Field, 1989; Sheppard and May, 1989), Herpesvirus
saimiri (Honess et al., 1989), marmoset herpesvirus (Otsuka
and Kit, 1984), varicella zoster virus (Littler et al., 1986),
herpesvirus of turkeys, Marek's disease virus (Scott et al .,
1989),

and Epstein-Barr virus

(Littler et

al.,

1986)

all

contain their respective Tk genes in the unique long regions
of the genome.

Generally the Tks are contained in a gene

'casette' which also contains the genes coding for the major
capsid protein and the homolog of HSV glycoprotein H (Albrecht
and Fleckenstein, 1990; Davison and Taylor, 1987).

In other

a herpesviruses the short repeat regions code for regulatory
proteins.

These results, along with the unique
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G K S T G G K E P R K Q L A T K A A R K
GGAAAATCCACCGGTGGCAAGGAGCCAAGGAAGCAGCTCGCCACTAAGGCTGCCCGCAAG
S A P Y T G G V K K P H R Y K P G T V A
AGCGCACCGTATACCGGCGGTGTGAAGAAGCCTCACCGTTACAAGCCCGGCACCGTGGCT
L R E I R R Y Q K S T E L L I
C K L H F
CTGAGGGAGATCCGCCGTTATCAGAAGTCTACTGAGCTGCTCATCTGCAAGCTGCACTTC
Q H L V R K I A Q D L K I
D L C F Q X A
CAGCACCTGGTGAGAAAAATCGCTCAGGACCTCAAGATCGACTTGTGTTTCCAGAGNGCC
L G A L Q E A S E A Y L V G L F E D T N
CTAGGGGCCCTGCAGGAGGCGAGCGAGGCATACCTTGTCGGTCTGTTCGAGGACACCAAC
L C S I H A K G V I G I
CTGTGCTCTATCCACGCCAAGGGAGTGATCGGCATC

Figure 2.
The nucleotide sequence and deduced amino acid
sequence of the presumptive coding strand of the PCR
generated fragment 405.
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405 GKSTGGKEPRKQLATKAARKSAPYTGGVKKPHRYKPGTVALREIRRYQKSTELLIC
****

*

****

VAC1GKSTEL..................................IRRVRRYQIAQYKCVT
VAR2GKSTEL..................................IRRVRRYQIAQYKCVT
SFV3 GKSTEL..................................IRLVRRYQIAKHKCLV
MPV4GKSTEL..................................IRRVRRYQIAQYKCVT
FPV5GKTSEL..................................VRRIKRFMLSNRKCII
HUM6GKSTEL..................................MRRVRRFQIAQYKCLV
MUS7GKSTEL..................................MRRVRRFQIAQYKCLV
CHK8 GKSTEL..................................MRRVRRFQLAQYRCLL

KLHFQHLVRKIAQDLKIDLCFQXALGALQEASEAYLVGLFEDTNLCSIHAKGVIGI
**

**

****

IKYSNDNRY___GTGLNTHDKNN
FEALEATKLCDVL.E ...SITDFSVIGI
IKYSNDNRY___GTGLWTHDKNN. ...FEALEATKLCDVL. EA. ..ITDFSVIGI
VKYEKDIRY___GNGVCTHDNMS
ITAVCTPSLDKIDSVA
ENAEVIGI
IKYSNDNRY___GTGLWTHDKNN
FAALEVTKLCDVL.EA...ITDFSVIGI
IKHCGDNRYNEDDINKYYTHDLLF___ MEATASSNLSVLVPTLL..NDGVQVIGI
IKYAKDTRY___SSSFCTHDRNT
MEALPACLLRDVAQEAL
GVAVIGI
IKYAKDTRY___SNSFSTHDRNT....MDALPACMLRDVTQELL
GVAVIGI
VKYAKDTRY. ..CTTGVSTHDRNT___ MEARPACALQDVYQEAL____GSAVIGI

Figure 3. A comparison of the deduced amino acid sequence of
fragment 405 with the amino acid sequences poxvirus and
vertebrate cytoplasmic Tk's. * indicates regions of 405
with homology to Tk sequences.
vaccinia virus, Hruby et al., 1983 variola virus, Esposito and Kniaht, 1984 Shope fibroma virus, Upton and
McFadden, 1986 monkey poxvirus, Esposito and Knight, 1984 fowlpox virus, Boyle et al., 1987 'hum an,
Bradshaw and Deininger, 1984 mouse, Lewis, 1986 'chicken, Kwoh and Engels, 1984.

395
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Figure 4.
DNA-DNA hybridization of Eco RI digested 0.7%
agarose gel electrophoresed CCV and cosmid DNA using 32P
labelled PCR fragment 405 as a probe.

substrate specificity of CCV-Tk (Chapter Three) , indicate that
the

channel

catfish

herpesvirus

may

show

divergence from the mammalian herpesviruses.

considerable
The results of

the degenerate based PCR experiments provide some support for
the marker-rescue results.

The one sequenced PCR fragment

that showed some homology to cytoplasmic and poxvirus Tk's
hybridized to the Eco RI K and L fragments of CCV and to the
Eco RI L fragment of cosmid 389.
the direct repeat regions.
because

the

conditions

reactions
and

the

represent

the

Tk

performed

reactions

gene,

vertebrate cytoplasmic
Tk's.

The PCR data is non definitive

were

quantities of contaminants.

These fragments are within

are

under

non-stringent

sensitive

to

minute

If the sequenced PCR product does
the

CCV-Tk

is

more

related

to

and poxvirus Tk's than herpesvirus

Research is currently in progress to sequence this

region of the genome to confirm the presence of the Tk gene.
A comparison of CCV-Tk and other viral Tk sequences may give
insight

into

herpesviruses.

the

evolution

of

this

enzyme

and

the
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Chapter Four
The Use of Ciprofloxacin to Cure
Mycoplasma Contaminated Channel Catfish Ovary Cells

Introduction
Mycoplasmas

(MP)

are

common,

contaminants of cell culture.
can be subtle or extreme,

yet

often

inapparent

Their effects on cultured cells

ranging from altered nutritional

requirements and changes in physical appearance to metabolic
changes and altered virus production characteristics (reviewed
by Barile, 1979).

Elimination of mycoplasma contamination is

essential in any experiments involving detailed analysis of
cellular enzymes.
During an investigation into cellular and channel catfish
virus induced thymidine kinase isozymes, MP contamination was
discovered in both the channel catfish ovary cell line (CCO)
and a thymidine kinase deficient mutant of the same cells
(CCOBr).

The contaminant evaded detection during

initial

screenings using standard MP culture methods but was detected
using a commercially available genetic probe to MP ribosomal
RNA.

Schmitt et al.

mammalian

cell

(1988) efficiently eliminated MP from

lines

using
81

the

4-flouroquinalone,
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Ciprofloxacin (CIP). The ability of CIP to cure contaminated
CCO cell lines was investigated.

Materials and Methods
All

cell

lines

were

routinely

passed

in

Dulbecco's

modified minimal essential medium + 10% fetal calf serum +
HEPES buffer + 50 /Ltg/ml gentamicin or 100 IU/ml penicillin and
100 nq/ml streptomycin.

CCOBr cells were cultured in the

presence of 500 jxq/ml 5-bromo-2'-deoxyuridine. Ciprofloxacin
tablets were dissociated in distilled water at a concentration
of 10 mg/ml.
growth

This suspension was dissolved in antibiotic free

medium

sterilized.

at

the

appropriate

dilution

and

filter

To find the highest dose of CIP tolerated by CCO

cells, MP contaminated CCO cells were cultured in the presence
of 10 /^g/ml, 50 jLtg/ml and 100 M9/rol CIP for 10 days at 30 C.
Mycoplasma cultures were prepared by centrifuging antibiotic
free culture medium from 7 day old cell cultures at 5000g for
30 min,

resuspending the pellet

in

100 n 1 of medium and

inoculating it on modified Hayflick's agar medium (Stalheim,
1973).

To identify any bacterial contaminants in the cell

cultures, a portion of the centrifuged cell culture medium was
cultured on 5% blood agar medium at 30 C.
hybridization

analyses

were

performed

Ribosomal RNA based
according

to

the

manufacturer's recommendations (Mycoplasma T.C., Gene Probe)
except that 10 ml of tissue culture medium were centrifuged
for analysis and hybridization times were increased to 16

83
hours to improve sensitivity.

Results
Doses of 50 and 100 /Ltg/ml of CIP produced subleathal
toxic changes characterized by reduced growth and a flattened
appearance of the cells.

Cells

in 10 fig/ml CIP did not

produce the distinct morphological changes observed in the
higher doses.

Because the 100 Mg/rol dose cells survived, this

level was used to evaluate the MP elimination.

The 100 fig/ml

CIP treated cells were cultured for two weeks in antibiotic
free medium and again analyzed for MP.

Table 1 shows that CIP

treated cells were negative for MP while untreated cultures
and cultures grown in medium containing 50 /xg/ml gentamicin
remained MP positive.

Bacterial screening plates revealed

tiny <0.5 mm hemolytic colonies on the blood agar after two
weeks,

even though the MP plates grown at

negative.

37 C remained

When replated on MP medium and incubated at 30 C

instead of the standard 37 C, tiny fried-egg shaped colonies
characteristic of MP appeared after two weeks.

Subsequently,

CCOBr cells cultured in the presence of 100 ng/ml CIP for 10
days at 30 C followed by two weeks in antibiotic free media
were also free of MP contamination.

Treated

CCO and CCOBr

cells subcultured in normal growth medium and intermittently
analyzed for MP contamination remained MP free after 2 or 4.5
months of continuous culture
cured.

(Table 1) and were considered
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Table 1.
results

Percent Hybridization of Mycoplasma Assays.
above

0.6%

are

positive.

Positive

and

All

negative

controls are supplied by the manufacturer.

1 month

2 months

CCO

51.60

37.00

CCO Gentamycin

53.80

ND

ND

0.15

0.15

0.18

45.20

33.40

ND

ND

0.16

0.08

negative control

0.07

0.11

0.49

positive control

64.00

73.60

sample

4 . 5

months

CCO Ciprofloxacin
CCOBr
CCOBr Ciprofloxacin

61.03

*ND- not determined.

ND1
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During the 100

m g/ml

CIP treatments all cells became

flattened and grew slowly.

Two to three passes in normal

medium were required for the cells to regain the normal growth
characteristics.

Discussion
CCO

cells

are the

channel catfish virus

cell

(CCV)

line

of

choice

for studying

(Bowser and Plumb,

1980).

It

produces higher titers of infectious virus, replicates faster
and is less sensitive to variables in tissue culture medium
than other CCV permissive cell lines.

Personal communications

with other labs indicate that mycoplasma contamination

is

prevalent in this cell line, contraindicating the use of these
cells

in

enzyme

studies.

Our

results

indicate

that

Ciprofloxacin at 100 ng/ml of culture medium can be used to
effectively eliminate MP contamination from fish cell lines.
Schmitt

et

different

al.

(1988)

species

of

were
MP

from

successful

in

eliminating

experimentally

7

contaminated

mammalian cell lines using 10 jug/ml CIP for 10 days at 37 C.
They found that levels higher than 10 /ng/ml affected protein
synthesis in specialized cell lines such as hybridomas and
lymphokine producing tumor cells.

In this study the minimal

inhibiting concentration of CIP on the contaminating MP at 30
C was not known and the maintanance of a specialized cell type
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was

not

neccessary.

Therefore,

contaminated

cells

were

cultured in the presence of the highest CIP levels tolerable.
A gradient of doses of CIP is recommended in treating other
fish cell lines that may be more sensitive or have specialized
functions.
The temperature sensitive nature of the MP contaminating
these piscine derived cell lines indicates a possible piscine
origin rather than the human, bovine or porcine species that
commonly

contaminate

sensitivity

also

cell

illustrates

cultures.
the

need

This
for

temperature

incubating

MP

diagnostic cultures at the normal incubation temperature for
the host cell.

The genetic probe kit proved to be

sensitive

fast

and

method

for

screening

a simple,

poikilothermic

vertebrate cell lines for MP and could be used routinely in
laboratories with access to a liquid scintillation counter.
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Summary

Live vaccine agents should improve the efficiency of
vaccination for extensive aquaculture programs.
live

vaccines

can

be

constructed

which

are

Recombinant
safer,

more

efficient and provide a broader spectrum of protection than
naturally attenuated pathogens.

This research established the

foundation for developing a channel catfish virus (CCV) based
vaccine

vector

system.

thymidine kinase
highly

efficient

(Tk) .

First,

CCV

was

shown

to

encode

This gene has been shown to be a

selectable

and

attenuating

selectable recombination in other herpesviruses.

marker

for

Thymidine

kinase negative mutants of CCV (CCVAr) and the channel catfish
ovary (CCO) cell line (CCOBr) were developed that were pivotal
in identifying and biochemically characterizing the viral Tk.
Next,

the CCV genome

was

cloned

into cosmid

and plasmid

prokaryotic vectors, allowing the viral Tk gene to be mapped
by identifying the cloned fragments which recombined with the
Tk negative virus, making it Tk positive.

This established

the methods for producing recombinant CCV, provided a valuable
library for future CCV research and tentatively located the
Tk gene.
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